Porth Ymchwil

Cost-effectiveness of pharmacogenetic-guided dosing of warfarin in the United Kingdom and Sweden

Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

StandardStandard

Cost-effectiveness of pharmacogenetic-guided dosing of warfarin in the United Kingdom and Sweden. / Verhoef, T.I.; Redekop, W.K.; Langenskiold, S et al.
Yn: The Pharmacogenomics Journal, Cyfrol 16, 10.2016, t. 478–484.

Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

HarvardHarvard

Verhoef, TI, Redekop, WK, Langenskiold, S, Kamali, F, Wadelius, M, Burnside, G, Maitland-van der Zee, AH, Hughes, D & Pirmohamed, M 2016, 'Cost-effectiveness of pharmacogenetic-guided dosing of warfarin in the United Kingdom and Sweden', The Pharmacogenomics Journal, cyfrol. 16, tt. 478–484. https://doi.org/10.1038/tpj.2016.41

APA

Verhoef, T. I., Redekop, W. K., Langenskiold, S., Kamali, F., Wadelius, M., Burnside, G., Maitland-van der Zee, A. H., Hughes, D., & Pirmohamed, M. (2016). Cost-effectiveness of pharmacogenetic-guided dosing of warfarin in the United Kingdom and Sweden. The Pharmacogenomics Journal, 16, 478–484. https://doi.org/10.1038/tpj.2016.41

CBE

Verhoef TI, Redekop WK, Langenskiold S, Kamali F, Wadelius M, Burnside G, Maitland-van der Zee AH, Hughes D, Pirmohamed M. 2016. Cost-effectiveness of pharmacogenetic-guided dosing of warfarin in the United Kingdom and Sweden. The Pharmacogenomics Journal. 16:478–484. https://doi.org/10.1038/tpj.2016.41

MLA

Verhoef, T.I. et al. "Cost-effectiveness of pharmacogenetic-guided dosing of warfarin in the United Kingdom and Sweden". The Pharmacogenomics Journal. 2016, 16. 478–484. https://doi.org/10.1038/tpj.2016.41

VancouverVancouver

Verhoef TI, Redekop WK, Langenskiold S, Kamali F, Wadelius M, Burnside G et al. Cost-effectiveness of pharmacogenetic-guided dosing of warfarin in the United Kingdom and Sweden. The Pharmacogenomics Journal. 2016 Hyd;16:478–484. Epub 2016 Meh 7. doi: 10.1038/tpj.2016.41

Author

Verhoef, T.I. ; Redekop, W.K. ; Langenskiold, S et al. / Cost-effectiveness of pharmacogenetic-guided dosing of warfarin in the United Kingdom and Sweden. Yn: The Pharmacogenomics Journal. 2016 ; Cyfrol 16. tt. 478–484.

RIS

TY - JOUR

T1 - Cost-effectiveness of pharmacogenetic-guided dosing of warfarin in the United Kingdom and Sweden

AU - Verhoef, T.I.

AU - Redekop, W.K.

AU - Langenskiold, S

AU - Kamali, F.

AU - Wadelius, M.

AU - Burnside, G.

AU - Maitland-van der Zee, A.H.

AU - Hughes, Dyfrig

AU - Pirmohamed, Munir

PY - 2016/10

Y1 - 2016/10

U2 - 10.1038/tpj.2016.41

DO - 10.1038/tpj.2016.41

M3 - Article

VL - 16

SP - 478

EP - 484

JO - The Pharmacogenomics Journal

JF - The Pharmacogenomics Journal

SN - 1470-269X

ER -